farid moussavi-harami
University of Washington
Seattle, United States
Review Editor
Cardiovascular and Hematologic Drugs
University of Washington
Seattle, United States
Review Editor
Cardiovascular and Hematologic Drugs
University of Kinshasa
Kinshasa, Democratic Republic of Congo
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Loyola University Chicago
Chicago, United States
Review Editor
Cardiovascular and Hematologic Drugs
University of Hradec Králové
Hradec Králové, Czechia
Review Editor
Neurological Drugs
Nvidia (United States)
Santa Clara, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
Departamento de Sistemas Biológicos, División de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana
México City, Mexico
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Rheumazentrum Ostschweiz
St. Gallen, Switzerland
Review Editor
Anti-inflammatory and Immunomodulating Agents
Monash University
Melbourne, Australia
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Faculty of Pharmaceutical Sciences, Setsunan University
Hirakata, Japan
Review Editor
Anti-inflammatory and Immunomodulating Agents
Beiersdorf (Germany)
Hamburg, Germany
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Vanderbilt University Medical Center
Nashville, United States
Review Editor
Cardiovascular and Hematologic Drugs
AstraZeneca (United States)
Wilmington, United States
Review Editor
Anti-inflammatory and Immunomodulating Agents
Bristol Myers Squibb (United States)
New York, United States
Review Editor
Anti-Cancer Drugs
Indraprastha Institute of Information Technology Delhi
Delhi, India
Review Editor
Technologies and Strategies to Enable Drug Discovery
Joyobrato Nath
Silchar, India
Review Editor
Neurological Drugs
Juiz de Fora Federal University
Juiz de Fora, Brazil
Review Editor
Anti-Infective Agents